UROLOGIX TARGIS SYSTEM FOR TREATMENT OF BPH
FDA premarket approval P970008/S020 · decided 2002-04-10
Approval details
- PMA number
- P970008
- Supplement
- S020
- Supplement type
- Real-Time Process
- Supplement reason
- Labeling Change - Indications/instructions/shelf life/tradename
- Trade name
- UROLOGIX TARGIS SYSTEM FOR TREATMENT OF BPH
- Generic name
- System, hyperthermia, rf/microwave (benign prostatic hyperplasia),thermotherapy
- Applicant
- Urologix, LLC
- Date received
- 2002-03-29
- Decision date
- 2002-04-10
- Days to decision
- 12 days
- Decision code
- APPR
- Product code
- MEQ
- Advisory committee
- Gastroenterology, Urology
- Expedited review
- No
- Location
- Plymouth, MN
- Statement
- APPROVAL FOR CHANGES TO THE "CONTRAINDICATIONS" AND PRECAUTIONS" SECTIONS OF THE LABELING.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.